VeriChip Corporation Announces Sale of VeriTrace System to Kentucky’s Green River District Health Department
10 8월 2009 - 9:30PM
Business Wire
VeriChip Corporation (NASDAQ:CHIP) (“VeriChip”), a provider of
radio frequency identification (RFID) systems for healthcare and
patient-related needs, announced today that it has sold the
VeriTrace™ system, including 1,000 RFID microchips, for disaster
preparedness and emergency management needs to Kentucky’s Green
River District Health Department.
VeriTrace, created in the aftermath of Hurricane Katrina where
it was used by the Federal Disaster Mortuary Operational Response
Team, was designed to assist in the management of emergency
situations and disaster recovery using implantable RFID technology.
The VeriTrace system includes a unique implantable RFID microchip,
a VeriTrace Bluetooth(TM) handheld reader, a customized Ricoh 500SE
Digital Camera capable of receiving both RFID scanned data and GPS
data wirelessly, and a Web-enabled database for gathering and
storing information and images captured during emergency response
operations. This database ensures the precise collection, storage
and inventory of all data and images related to remains and the
associated evidentiary items. This also allows the recreation of an
accurate and complete reconstruction of a disaster setting, crime
scene or similar setting where recreation is necessary.
Marc Poulshock, Vice President of VeriChip’s Implantable and
Emergency Management divisions, said, “Our continued outreach helps
health care organizations and various levels of government
recognize the role the VeriTrace System, the only end-to-end
solution to use implantable RFID tags for disaster preparedness and
emergency response, plays in meeting their needs.”
About VeriChip Corporation
VeriChip Corporation, headquartered in Delray Beach, Florida,
has developed the VeriMed™ Health Link System for rapidly and
accurately identifying people who arrive in an emergency room and
are unable to communicate. This system uses the first
human-implantable passive RFID microchip, cleared for medical use
in October 2004 by the United States Food and Drug Administration.
To complement its healthcare division, VeriChip Corporation
established VeriGreen Energy Corporation in March 2009 to focus and
invest in the clean and alternative energy sector.
For more information on VeriChip, please call 1-800-970-2447, or
e-mail info@verichipcorp.com. Additional information can be found
online at www.verichipcorp.com.
Statements about VeriChip’s future expectations, including
future revenues and earnings from the sale of VeriTrace, and all
other statements in this press release other than historical facts
are “forward-looking statements” within the meaning of Section 27A
of the Securities Act of 1933, Section 21E of the Securities
Exchange Act of 1934, and as that term is defined in the Private
Litigation Reform Act of 1995. Such forward-looking statements
involve risks and uncertainties and are subject to change at any
time, and VeriChip’s actual results could differ materially from
expected results. Additional information about these and other
factors that could affect the Company’s business is set forth in
the Company’s various filings with the Securities and Exchange
Commission, including those set forth in the Company’s 10-K filed
on February 12, 2009, under the caption “Risk Factors.” The Company
undertakes no obligation to update or release any revisions to
these forward-looking statements to reflect events or circumstances
after the date of this statement or to reflect the occurrence of
unanticipated events, except as required by law.
Verichip (MM) (NASDAQ:CHIP)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Verichip (MM) (NASDAQ:CHIP)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024
